“…The first decade of the new millennium has apparently inspired the launch of comprehensive projects dedicated specifically to rare pediatric tumors. National cooperative groups focusing on this field have been founded in several European countries, including: the Italian TREP (Tumori Rari in Età Pediatrica -Rare Tumors in Pediatric Age) project, begun in 2000 under the auspices of the Associazione Italiana Ematologia Oncologia Pediatrica in cooperation with the Società Italiana Chirurgia Pediatrica [3,5]; the Rare Tumour Working Group of the United Kingdom's Children's Cancer & Leukaemia Group, which started operating in 1997 [6]; the Polish Pediatric Rare Tumors Study Group, founded in 2002 as part of the Polish Pediatric Solid Tumors Study Group [7]; the German Rare Tumor Working Group, created in 2006 as part of the German Society of Pediatric Oncology and Hematology [8,9]; and the French groupe francais des tumeurs rares de l'enfant, founded in 2007 by the French Pediatric Oncological Society in association with the French National Cancer Registry [10]. Although the organizational aspects and levels of activity of these different schemes varied considerably, all these groups were able to collect clinical data and establish a collaborative network with other specialists (i.e., adult oncologists, surgeons, endocrinologists and dermatologists) involved in managing the tumors of interest, as well as prompting research, developing diagnostic and therapeutic recommendations, and providing treatment centers with an advisory service.…”